# Provident Financial Holdings Inc: overview PROV · Nasdaq · CIK 1010470 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/prov.md) · [Financials](/companies/prov/financials.md) · [Filings](/companies/prov/filings.md) · [Insiders](/companies/prov/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.28](/filings/0001010470-25-000005.md) | [0.13](/filings/0001010470-26-000003.md) | [0.28](/filings/0001010470-26-000007.md) | not reported | [0.25](/filings/0001010470-25-000005.md) | [0.22](/filings/0001010470-26-000003.md) | [0.21](/filings/0001010470-26-000007.md) | not reported | | Free cash flow | $k | [2,388](/filings/0001010470-25-000005.md) | [307 d](/filings/0001010470-26-000003.md) | [3,293 d](/filings/0001010470-26-000007.md) | [2,167 d](/filings/0001010470-26-000010.md) | [2,452](/filings/0001010470-25-000005.md) | [1,032 d](/filings/0001010470-26-000003.md) | [1,745 d](/filings/0001010470-26-000007.md) | [3,309 d](/filings/0001010470-26-000010.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.22](/filings/0000939057-23-000267.md) | [1.19](/filings/0000939057-24-000247.md) | [1.06](/filings/0000939057-25-000242.md) | [0.93](/filings/0001010470-26-000010.md) | [1.03](/filings/0001010470-26-000010.md) | | Free cash flow | $m | [11.6](/filings/0000939057-23-000267.md) | [15.6](/filings/0000939057-24-000247.md) | [4.1](/filings/0000939057-25-000242.md) | [8.2](/filings/0001010470-26-000010.md) | [8.5](/filings/0001010470-26-000010.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/prov/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $8.4m | 490,819 | | Added +409 | | [RAFFLES ASSOCIATES LP](/funds/1169581.md) | 2026-06-30 | $6.7m | 391,118 | | Unchanged | | [RAFFLES ASSOCIATES LP](/funds/1169581.md) | 2026-06-30 | $6.7m | 391,118 | | Unchanged | | [Fourthstone LLC](/funds/1767803.md) | 2026-06-30 | $6.4m | 369,973 | | Added +4,341 | | [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $5.2m | 303,733 | | Reduced −2,701 | | [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $4.8m | 281,949 | | Reduced −878 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $4.8m | 281,656 | | Added +5,720 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.1m | 239,883 | | Reduced −206 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $3.6m | 211,347 | | Reduced −1,006 | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $1.2m | 69,795 | | Added +741 | ## Recent filings [All 649 filings](/companies/prov/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 13:11 ET | [8-K](/filings/0000939057-26-000275.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000939057-26-000275 | | 2026-10-23 | 12:48 ET | [8-K](/filings/0000939057-26-000273.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000939057-26-000273 | | 2026-10-09 | 12:59 ET | [DEF 14A](/filings/0001104659-26-114953.md) | Proxy statement, period 2026-11-19 | 0001104659-26-114953 | | 2026-09-02 | 15:19 ET | [10-K](/filings/0001010470-26-000010.md) | Annual report, period 2026-06-30 | 0001010470-26-000010 | | 2026-07-28 | 12:19 ET | [8-K](/filings/0000939057-26-000143.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000939057-26-000143 | | 2026-07-24 | 11:31 ET | [8-K](/filings/0000939057-26-000138.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000939057-26-000138 | | 2026-07-24 | 10:05 ET | [8-K](/filings/0000939057-26-000136.md) | 5.02 Departure or appointment of officers or directors | 0000939057-26-000136 | | 2026-05-28 | 16:01 ET | [8-K](/filings/0000939057-26-000120.md) | 5.02 Departure or appointment of officers or directors | 0000939057-26-000120 | | 2026-05-07 | 15:06 ET | [10-Q](/filings/0001010470-26-000007.md) | Quarterly report, period 2026-03-31 | 0001010470-26-000007 | | 2026-04-28 | 12:02 ET | [8-K](/filings/0000939057-26-000092.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000939057-26-000092 | ## Latest annual report [Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001010470-26-000010.md), filed Sep 2, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1010470 - Tickers: PROV - Exchange: Nasdaq - SIC code: 6035 Savings Institution, Federally Chartered - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 11:49 ET. No prices; not investment advice.